Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is common in severe coronavirus disease 2019 (COVID-19) and worsens the prognosis. Sildenafil, a phosphodiesterase-5 inhibitor, is approved for PAH treatment but little is known about its efficacy in cases of severe COVID-19 with PAH. This study aimed to investi...

Full description

Bibliographic Details
Main Authors: Oleksandr Valentynovych Oliynyk, Marta Rorat, Olena Vadymivna Strepetova, Serhij Oleksandrovych Dubrov, Vitaliy Grygorovych Guryanov, Yanina Volodymyrivna Oliynyk, Oleksii Serhijovych Kulivets, Anna Ślifirczyk, Wojciech Barg
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
SARS-CoV-2
respiratory failure
pulmonary artery pressure
sildenafil
Online Access:https://www.mdpi.com/1999-4915/15/5/1157

Internet

https://www.mdpi.com/1999-4915/15/5/1157

Similar Items